aTyr Pharma, Inc. (ATYR)
NASDAQ: ATYR · Real-Time Price · USD
0.4700
-0.0430 (-8.38%)
At close: Jun 5, 2026, 4:00 PM EDT
0.4739
+0.0039 (0.83%)
After-hours: Jun 5, 2026, 7:53 PM EDT
aTyr Pharma Revenue
aTyr Pharma had revenue of $190.00K in the twelve months ending March 31, 2026. In the year 2025, aTyr Pharma had annual revenue of $190.00K, down -19.15%.
Revenue (ttm)
$190.00K
Revenue Growth
-19.15%
P/S Ratio
242.55
Revenue / Employee
$3,167
Employees
60
Market Cap
46.08M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 190.00K | -45.00K | -19.15% |
| Dec 31, 2024 | 235.00K | -118.00K | -33.43% |
| Dec 31, 2023 | 353.00K | -10.03M | -96.60% |
| Dec 31, 2022 | 10.39M | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | 10.46M | 10.03M | 2,377.49% |
| Dec 31, 2019 | 422.00K | - | - |
| Dec 31, 2018 | - | - | - |
| Dec 31, 2017 | - | - | - |
| Dec 31, 2016 | - | - | - |
| Dec 31, 2015 | - | - | - |
| Dec 31, 2014 | - | - | - |
| Dec 31, 2013 | - | - | - |
| Dec 31, 2012 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Xilio Therapeutics | 53.48M |
| Metagenomi Therapeutics | 22.33M |
| Nutriband | 2.04M |
| Hyperion DeFi | 1.04M |
| Mereo BioPharma Group | 500.00K |
ATYR News
- 3 days ago - aTyr Pharma Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 12 days ago - Forget the SpaceX IPO. These 2 New Stocks Stand Out Right Now. - Barrons
- 17 days ago - Ethos Partners with Baseball Legend David Ortiz to Champion Life Insurance as a Family Financial Essential - GlobeNewsWire
- 18 days ago - aTyr Pharma upgraded to Buy from Hold at Freedom Broker - TheFly
- 23 days ago - Ethos to Present at Upcoming Investor Conferences - GlobeNewsWire
- 23 days ago - aTyr Pharma reports Q1 EPS (11c), consensus (15c) - TheFly
- 23 days ago - aTyr Pharma Announces First Quarter 2026 Results and Provides Corporate Update - GlobeNewsWire
- 23 days ago - aTyr Pharma Quarterly report: Q1 2026 - Filings